Cynosure's PicoSure Picosecond Laser approved in Korea and Taiwan Cynosure announced that its PicoSure Picosecond Laser has received marketing authorization in Korea from the country's Ministry of Food and Drug Safety and in Taiwan from the Taiwan Food and Drug Administration, or TFDA. The product will be marketed through the Company's direct sales force in Korea and through its third-party distributor in Taiwan.
Cynosure: SculpSure ahead of plan in first few months on market The company commented, "SculpSure is ahead of plan in just its first few months on the market and the early feedback has been encouraging. Given early demand from physicians and patients, we're optimistic about maintaining the initial trajectory as we move through the year. Our commitments to disciplined execution, technological innovation and prudent financial management are core to the foundation of Cynosure and will continue to anchor our strategy moving forward."